Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD

Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD

In this episode of the Psychedelic Medicine Podcast, Christian Jurlando, PhD, joins to unpack the topic of extended difficulties following psychedelic experiences. Dr. Jurlando is a humanities professor at Stevens Institute of Technology in Hoboken, NJ, and a researcher and advocate focused on psychedelic safety and extended post-psychedelic difficulties (EPPD). Drawing in part on his own lived experience of prolonged difficulties following psilocybin use, his work focuses on improving recognition, care, and support for people experiencing adverse psychedelic outcomes.

In this conversation, Dr. Jurlando discusses extended post-psychedelic difficulties, drawing on both research and his own experience of EPPD following a low dose of psilocybin. He explains that these difficulties can take many forms, may occur even after relatively small doses, and can persist long after the acute psychedelic experience has ended. The conversation explores how to distinguish acute crises and shorter-term difficulties from extended post-psychedelic difficulties, as well as the importance of recognizing when someone needs professional support. Dr. Jurlando also discusses the emerging infrastructure for supporting people who experience adverse psychedelic outcomes, including peer support, harm-reduction services, specialized clinics, and the development of clearer pathways for escalation and referral. Throughout, he emphasizes the importance of acknowledging these experiences within the psychedelic field, developing more nuanced approaches to risk and informed consent, and recognizing that recovery can take time and may involve different approaches for different people.

In this episode, you'll hear:

What extended post-psychedelic difficulties can look like and how they may differ from psychosis or other acute psychedelic complications

Four questions for assessing whether someone experiencing post-psychedelic difficulties may need additional support

How peer-support and harm-reduction services can identify when someone may need to be referred for more specialized care

What is currently known about risk factors, set and setting, and the prevalence of extended post-psychedelic difficulties

Why psychedelic risk needs to be considered in relation to the potential benefits and the individual circumstances of each patient

Quotes:

"In my research, I found that back in the late 50s, that was kind of the rule of thumb: that smaller doses were more dangerous because people didn't process what was coming up and could get stuck in a negative state." [5:16]

"The best estimate [of extended post-psychedelic difficulties] that we have right now is from the Global Psychedelic Survey… over 6400 people were surveyed and 8% reported difficulties lasting a month or longer that meaningfully disrupted their daily functioning." [10:43]

"It's very difficult when something presents so fast to realize that the remedy or getting better takes time. It takes, in fact, sometimes a lot of time. And there can be a lot of resistance to that because you think 'hey, if I just took some mushrooms and then suddenly felt this way, surely I can just take something else and suddenly feel better, right?' It doesn't work that way. And so I think that that's sort of an added level of distress, and it's maybe unique." [13:59]

"What we're finding is that what people really need is just acknowledgment that these sorts of things happen. That's the first thing that would have been really helpful for me—because when you're in that state and you think that you've broken your brain or something, then it can just start snowballing." [17:37]

"It does seem like there's a wide variety of treatments [for extended post-psychedelic difficulties] and some work for some [people] and some work for others." [32:05]

Links:

Dr. Jurlando on LinkedIn

Dr. Jurlando's article: "The invention of challenging psychedelic experiences: Meaning, measurement, and foreclosure of extended harm"

Dr. Jurlando's article (pre-print): "Strengthening the Psychedelic Safety Net: A Call for a Coordinated Ecosystem of Post-Psychedelic Care"

Challenging Psychedelic Experiences Project website

Fireside Project website

Previous episode: The Challenging Psychedelic Experiences Project with Jules Evans

Previous episode: Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Psychedelic Medicine Association

Porangui

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(214)

What Happens to Relationships After Psychedelic-Assisted Therapy? with Shira Myrow, LMFT

What Happens to Relationships After Psychedelic-Assisted Therapy? with Shira Myrow, LMFT

In this episode of the Psychedelic Medicine Podcast, Shira Myrow, LMFT joins to discuss the impacts of psychedelic-assisted therapy on relationships. Shira is a couples psychotherapist with nearly two...

18 Nov 37min

Hallucinogen Persisting Perception Disorder (HPPD) with Steven Locke, MD, DLFAPA

Hallucinogen Persisting Perception Disorder (HPPD) with Steven Locke, MD, DLFAPA

In this episode of the Psychedelic Medicine Podcast, Steven Locke, MD, DLFAPA joins to discuss the intricacies of Hallucinogen Persisting Perception Disorder (HPPD). Dr. Locke is a former Associate Pr...

4 Nov 56min

Psilocybin for Phantom Limb Pain with Jon Dean, PhD

Psilocybin for Phantom Limb Pain with Jon Dean, PhD

In this episode of the Psychedelic Medicine Podcast, Jon Dean, PhD joins to discuss the potential of psilocybin therapies for phantom limb pain. Dr. Dean is an assistant professor at UC San Diego, whe...

21 Okt 36min

Psilocybin for PTSD with Stacey Armstrong, PhD

Psilocybin for PTSD with Stacey Armstrong, PhD

In this episode of the Psychedelic Medicine Podcast, Stacey Armstrong, PhD joins to discuss the latest research on psilocybin treatments for PTSD. Dr. Armstrong is Associate Director and Senior Resear...

7 Okt 37min

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counsellin...

9 Sep 35min

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 ...

27 Aug 39min

Encore Episode: Psychedelics and Breathwork with Kyle Buller

Encore Episode: Psychedelics and Breathwork with Kyle Buller

This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has...

13 Aug 43min

Populært innen Helse

fastlegen
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
rss-ekteskapet
fryktlos
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
rss-kunsten-a-leve
treningsprat
rss-lopedrommen
lydartikler-fra-aftenposten
rss-loping-for-nybegynnere
rss-kull
g-punktet
hjernesterk